Emerging applications of porphyrins in photomedicine

Frontiers in Physics

Volumn 3, Issue APR, 2015, Pages

  Huang, Haoyuan ^a   Song, Wentao ^a   Rieffel, James ^a   Lovell, Jonathan F ^a  

^a University at Buffalo The State University of New York   (United States)

Author keywords

Drug delivery; Metal chelation; Multimodal imaging; Oxygen sensing; Photodynamic molecular beacons; Photodynamic therapy; Porphyrins; Porphysomes

Indexed keywords

CONTROLLED DRUG DELIVERY; LIPOSOMES; MEDICAL APPLICATIONS; MEDICAL IMAGING; MOLECULAR OXYGEN; PHOTOSENSITIZERS; PORPHYRINS; SILICA NANOPARTICLES; TARGETED DRUG DELIVERY;

BIOMEDICAL APPLICATIONS; EMERGING APPLICATIONS; METAL CHELATION; MOLECULAR BEACON; MULTIMODAL IMAGING; OXYGEN-SENSING; PHOTODYNAMIC MOLECULAR BEACON; PHOTOSENSITISER; PHOTOTHERAPY; PORPHYSOME;

PHOTODYNAMIC THERAPY;

EID: 85106767709     PISSN: None     EISSN: 2296424X     Source Type: Journal    
DOI: 10.3389/fphy.2015.00023     Document Type: Review

References (174)

1. Zhang Y, Lovell JF. Porphyrins as theranostic agents from prehistoric to modern times. Theranostics (2012) 2:905-15. doi: 10.7150/thno.4908
2. Blamire AM, Ogawa S, Ugurbil K, Rothman D, McCarthy G, Ellermann JM, et al. Dynamic mapping of the human visual cortex by high-speed magnetic resonance imaging. Proc Natl Acad Sci USA. (1992) 89:11069-73. doi: 10.1073/pnas.89.22.11069
3. Belliveau JW, Kennedy DN, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science (1991) 254:716-9. doi: 10.1126/science.1948051
4. Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy. Bioconjug Chem. (2011) 22:1879-903. doi: 10.1021/bc200151q
5. Josefsen LB, Boyle RW. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics (2012) 2:916-66. doi: 10.7150/thno.4571
6. Berg K, Selbo PK, Weyergang A, Dietze A, Prasmickaite L, Bonsted A, et al. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J Microsc. (2005) 218:133-47. doi: 10.1111/j.1365-2818.2005.01471.x
7. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al. Photodynamic therapy. J Natl Cancer Inst. (1998) 90:889-905. doi: 10.1093/jnci/90.12.889
8. López Zeballos NC, García Vior MC, Awruch J, Dicelio LE. An exhaustive study of a novel sulfur-linked adamantane tetrasubstituted zinc(II) phthalocyanine incorporated into liposomes. J Photochem Photobiol A. (2012) 235:7-13. doi: 10.1016/j.jphotochem.2012.02.022
9. Kushwaha D, Tiwari VK. Click chemistry inspired synthesis of glycoporphyrin dendrimers. J Org Chem. (2013) 78:8184-90. doi: 10.1021/jo4012392
10. Stewart CN Jr. Monitoring the presence and expression of transgenes in living plants. Trends Plant Sci. (2005) 10:3906. doi: 10.1016/j.tplants.2005.06.003
11. Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater. (2011) 10:324-32. doi: 10.1038/nmat2986
12. Tu H-L, Lin Y-S, Lin H-Y, Hung Y, Lo L-W, Chen Y-F, et al. In vitro studies of functionalized mesoporous silica nanoparticles for photodynamic therapy. Adv Mater (2009) 21:172-7. doi: 10.1002/adma.200800548
13. Huang H, Song W, Chen G, Reynard JM, Ohulchanskyy TY, Prasad PN, et al. Pd-porphyrin-cross-linked implantable hydrogels with oxygen-responsive phosphorescence. Adv Healthc Mater. (2014) 3:891-6. doi: 10.1002/adhm.201300483
14. Jing L, Liang X, Li X, Lin L, Yang Y, Yue X, et al. Mn-porphyrin conjugated au nanoshells encapsulating doxorubicin for potential magnetic resonance imaging and light triggered synergistic therapy of cancer. Theranostics (2014) 4:858-71. doi: 10.7150/thno.8818
15. Liu TW, MacDonald TD, Jin CS, Gold JM, Bristow RG, Wilson BC, et al. Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases. ACS Nano (2013) 7:4221-32. doi: 10.1021/nn400669r
16. Hayashi K, Nakamura M, Ishimura K. Silica-porphyrin hybrid nanotubes for in vivo cell tracking by near-infrared fluorescence imaging. Chem Commun. (Camb.) (2012) 48:3830-2. doi: 10.1039/C2CC17444H
17. Pandey RK, Goswami LN, Chen Y, Gryshuk A, Missert JR, Oseroff A, et al. Nature: a rich source for developing multifunctional agents. tumor-imaging and photodynamic therapy. Lasers Surg Med. (2006) 38:445-67. doi: 10.1002/lsm.20352
18. Peng J, Zhao L, Zhu X, Sun Y, Feng W, Gao Y, et al. Hollow silica nanoparticles loaded with hydrophobic phthalocyanine for near-infrared photodynamic and photothermal combination therapy. Biomaterials (2013) 34:7905-12. doi: 10.1016/j.biomaterials.2013.07.027
19. Huynh E, Lovell JF, Helfield BL, Jeon M, Kim C, Goertz DE, et al. Porphyrin shell microbubbles with intrinsic ultrasound and photoacoustic properties. J Am Chem Soc. (2012) 134:16464-7. doi: 10.1021/ja305988f
20. Lovell JF, Roxin A, Ng KK, Qi Q, McMullen JD, DaCosta RS, et al. Porphyrin-cross-linked hydrogel for fluorescence-guided monitoring and surgical resection. Biomacromolecules (2011) 12:3115-8. doi: 10.1021/bm200784s
21. Liu K, Liu Y, Yao Y, Yuan H, Wang S, Wang Z, et al. Supramolecular photosensitizers with enhanced antibacterial efficiency. Angew Chem. (2013) 125:8443-7. doi: 10.1002/ange.201303387
22. Pereira PMR, Korsak B, Sarmento B, Schneider RJ, Fernandes R, Tome JPC. Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications. Org Biomol Chem. (2015) 13:2518-29. doi: 10.1039/C4OB02334J
23. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. (2003) 3:380-7. doi: 10.1038/nrc1071
24. Treatment of Age-related Macular Degeneration With Photodynamic Therapy Study G. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-tap report 1. Arch Ophthalmol. (1999) 117:1329-45. doi: 10.1001/archopht.117.10.1329
25. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B. (1997) 39:1-18. doi: 10.1016/S1011-1344(96)07428-3
26. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev. (1995) 24:19-33. doi: 10.1039/cs9952400019
27. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. (2004) 5:497-508. doi: 10.1016/S1470-2045(04)01529-3
28. Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev. (2015) 115:1990-2042. doi: 10.1021/cr5004198
29. Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat. (2005) 4:283-93. doi: 10.1177/153303460500400308
30. Yoon I, Li JZ, Shim YK. Advance in photosensitizers and light delivery for photodynamic therapy. Clin Endosc. (2013) 46:7-23. doi: 10.5946/ce.2013.46.1.7
31. Detty MR, Gibson SL, Wagner SJ. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem. (2004) 47:3897-915. doi: 10.1021/jm040074b
32. Allison RR, Downie GH, Cuenca R, Hu X-H, Childs CJH, Sibata CH. Photosensitizers in clinical PDT. Photodiagnosis Photodyn Ther. (2004) 1:27-42. doi: 10.1016/S1572-1000(04)00007-9
33. Ormond AB, Freeman HS. Dye sensitizers for photodynamic therapy. Materials (2013) 6:817-40. doi: 10.3390/ma6030817
34. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev. (2010) 110:2795-838. doi: 10.1021/cr900300p
35. Schweitzer C, Schmidt R. Physical mechanisms of generation and deactivation of singlet oxygen. Chem Rev. (2003) 103:1685-758. doi: 10.1021/cr010371d
36. DeRosa MC, Crutchley RJ. Photosensitized singlet oxygen and its applications. Coord Chem Rev. (2002) 233-234:351-71. doi: 10.1016/S0010-8545(02)00034-6
37. Agnez-Lima LF, Melo JTA, Silva AE, Oliveira AHS, Timoteo ARS, Lima-Bessa KM, et al. DNA damage by singlet oxygen and cellular protective mechanisms. Mutat Res. (2012) 751:15-28. doi: 10.1016/j.mrrev.2011.12.005
38. Feng D, Gu Z-Y, Li J-R, Jiang H-L, Wei Z, Zhou H-C. Zirconium-metalloporphyrin PCN-222: mesoporous metal-organic frameworks with ultrahigh stability as biomimetic catalysts. Angew Chem. (2012) 124:10453-6. doi: 10.1002/ange.201204475
39. Chen L, Yang Y, Jiang D. CMPs as scaffolds for constructing porous catalytic frameworks: a built-in heterogeneous catalyst with high activity and selectivity based on nanoporous metalloporphyrin polymers. J Am Chem Soc. (2010) 132:9138-43. doi: 10.1021/ja1028556
40. Che C-M, Lo VK-Y, Zhou C-Y, Huang J-S. Selective functionalisation of saturated C-H bonds with metalloporphyrin catalysts. Chem Soc Rev. (2011) 40:1950-75. doi: 10.1039/C0CS00142B
41. Borisov SM, Zenkl G, Klimant I. Phosphorescent Platinum(II) and Palladium(II) complexes with azatetrabenzoporphyrins-new red laser diode-compatible indicators for optical oxygen sensing. ACS Appl Mater Interfaces. (2010) 2:366-74. doi: 10.1021/am900932z
42. Wang X-D, Chen H-X, Zhao Y, Chen X, Wang X-R, Chen X. Optical oxygen sensors move towards colorimetric determination. TrAC Trends Anal Chem. (2010) 29:319-38. doi: 10.1016/j.trac.2010.01.004
43. Ceroni P, Lebedev AY, Marchi E, Yuan M, Esipova TV, Bergamini G, et al. Evaluation of phototoxicity of dendritic porphyrin-based phosphorescent oxygen probes: an in vitro study. Photochem Photobiol Sci. (2011) 10:1056-65. doi: 10.1039/C0PP00356E
44. Koo Lee Y-E, Ulbrich EE, Kim G, Hah H, Strollo C, Fan W, et al. Near infrared luminescent oxygen nanosensors with nanoparticle matrix tailored sensitivity. Anal Chem. (2010) 82:8446-55. doi: 10.1021/ac1015358
45. Sakadzic S, Roussakis E, Yaseen MA, Mandeville ET, Srinivasan VJ, Arai K, et al. Two-photon high-resolution measurement of partial pressure of oxygen in cerebral vasculature and tissue. Nat Methods. (2010) 7:755-9. doi: 10.1038/nmeth.1490
46. Lebedev AY, Cheprakov AV, Sakadzic S, Boas DA, Wilson DF, Vinogradov SA. Dendritic phosphorescent probes for oxygen imaging in biological systems. ACS Appl Mater Interfaces. (2009) 1:1292-304. doi: 10.1021/am9001698
47. Esipova TV, Karagodov A, Miller J, Wilson DF, Busch TM, Vinogradov SA. Two new 'Protected' oxyphors for biological oximetry: properties and application in tumor imaging. Anal Chem. (2011) 83:8756-65. doi: 10.1021/ac2022234
48. Vinogradov SA, Wilson DF. Metallotetrabenzoporphyrins. New phosphorescent probes for oxygen measurements. J Chem Soc Perkin Trans. (1995) 2:103-11. doi: 10.1039/P29950000103
49. Xiang H, Zhou L, Feng Y, Cheng J, Wu D, Zhou X. Tunable fluorescent/phosphorescent platinum(II) porphyrin-fluorene copolymers for ratiometric dual emissive oxygen sensing. Inorg Chem. (2012) 51:5208-12. doi: 10.1021/ic300040n
50. Cywinski PJ, Moro AJ, Stanca SE, Biskup C, Mohr GJ. Ratiometric porphyrin-based layers and nanoparticles for measuring oxygen in biosamples. Sens Actuators B. (2009) 135:472-7. doi: 10.1016/j.snb.2008.09.039
51. Sung T-W, Lo Y-L. Dual sensing of temperature and oxygen using PtTFPP-doped CdSe/SiO2 core-shell nanoparticles. Sens Actuators B. (2012) 173:406-13. doi: 10.1016/j.snb.2012.07.028
52. Kondrashina AV, Dmitriev RI, Borisov SM, Klimant I, O'Brien I, Nolan YM, et al. A phosphorescent nanoparticle-based probe for sensing and imaging of (Intra) cellular oxygen in multiple detection modalities. Adv Funct Mater. (2012) 22:4931-9. doi: 10.1002/adfm.201201387
53. Dunphy I, Vinogradov SA, Wilson DF. Oxyphor R2 and G2: phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescence. Anal Biochem. (2002) 310:191-8. doi: 10.1016/j.snb.2012.07.028
54. Finikova OS, Lebedev AY, Aprelev A, Troxler T, Gao F, Garnacho C, et al. Oxygen microscopy by two-photon-excited phosphorescence. Chem Phys Chem. (2008) 9:1673-9. doi: 10.1002/cphc.200800296
55. Briñas RP, Troxler T, Hochstrasser RM, Vinogradov SA. Phosphorescent oxygen sensor with dendritic protection and two-photon absorbing antenna. J Am Chem Soc. (2005) 127:11851-62. doi: 10.1021/ja052947c
56. López-Ruiz N, Martínez-Olmos A, Pérez de Vargas-Sansalvador IM, Fernández-Ramos MD, Carvajal MA, Capitan-Vallvey LF, et al. Determination of O2 using colour sensing from image processing with mobile devices. Sens Actuators B. (2012) 171-172:938-45. doi: 10.1016/j.snb.2012.06.007
57. Cheng S-H, Lee C-H, Yang C-S, Tseng F-G, Mou C-Y, Lo L-W. Mesoporous silica nanoparticles functionalized with an oxygen-sensing probe for cell photodynamic therapy: potential cancer theranostics. J Mater Chem. (2009) 19:1252-7. doi: 10.1039/b816636f
58. Cheng S-H, Lee C-H, Chen M-C, Souris JS, Tseng F-G, Yang C-S, et al. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics-the trio of imaging, targeting and therapy. J Mater Chem. (2010) 20:6149-57. doi: 10.1039/c0jm00645a
59. Shi J, Liu TWB, Chen J, Green D, Jaffray D, Wilson BC, et al. Transforming a targeted porphyrin theranostic agent into a PET imaging probe for cancer. Theranostics (2011) 1:363-70. doi: 10.7150/thno/v01p0363
60. Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol. (2009) 13:256-62. doi: 10.1016/j.cbpa.2009.03.022
61. Zhang Y, Jeon M, Rich LJ, Hong H, Geng J, Zhang Y, et al. Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines. Nat Nanotechnol. (2014) 9:631-8. doi: 10.1038/nnano.2014.130
62. Takehara Y, Sakahara H, Masunaga H, Isogai S, Kodaira N, Takeda H, et al. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice. Br J Cancer. (2001) 84:1681-5. doi: 10.1054/bjoc.2001.1802
63. Cheng W, Haedicke IE, Nofiele J, Martinez F, Beera K, Scholl TJ, et al. Complementary strategies for developing gd-free high-field T1 MRI contrast agents based on MnIII porphyrins. J Med Chem. (2014) 57:516-20. doi: 10.1021/jm401124b
64. Lovell JF, Liu TWB, Chen J, Zheng G. Activatable photosensitizers for imaging and therapy. Chem Rev. (2010) 110:2839-57. doi: 10.1021/cr900236h
65. Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol. (1996) 14:303-8. doi: 10.1038/nbt0396-303
66. Fabbrizzi L, Licchelli M, Pallavicini P, Sacchi D, Taglietti A. Sensing of transition metals through fluorescence quenching or enhancement. A review. Analyst (1996) 121:1763-8. doi: 10.1039/AN9962101763
67. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nat Biotechnol. (1998) 16:49-53. doi: 10.1038/nbt0198-49
68. Dubertret B, Calame M, Libchaber AJ. Single-mismatch detection using gold-quenched fluorescent oligonucleotides. Nat Biotechnol. (2001) 19:365-70. doi: 10.1038/86762
69. Lovell JF, Chen J, Jarvi MT, Cao W-G, Allen AD, Liu Y, et al. FRET Quenching of photosensitizer singlet oxygen generation. J Phys Chem B. (2009) 113:3203-11. doi: 10.1021/jp810324v
70. Lovell JF, Zheng G. Activatable smart probes for molecular optical imaging and therapy. J Innov Opt Health Sci. (2008) 1:45-61. doi: 10.1142/S1793545808000157
71. Lou K, Lovell JF. A quenched binuclear ruthenium(II) dimer activated by another photosensitizer. Chem Commun. (Camb.) (2014) 50:3231-3. doi: 10.1039/C3CC49171D
72. Chen J, Lovell JF, Lo P-C, Stefflova K, Niedre M, Wilson BC, et al. A tumor mRNA-triggered photodynamic molecular beacon based on oligonucleotide hairpin control of singlet oxygen production. Photochem Photobiol Sci. (2008) 7:775-81. doi: 10.1039/B800653A
73. Lovell JF, Chen J, Huynh E, Jarvi MT, Wilson BC, Zheng G. Facile synthesis of advanced photodynamic molecular beacon architectures. Bioconjug Chem. (2010) 21:1023-5. doi: 10.1021/bc100178z
74. Lovell JF, Jin H, Ng KK, Zheng G. Programmed nanoparticle aggregation using molecular beacons. Angew Chem Int Ed Engl. (2010) 49:7917-9. doi: 10.1002/anie.201003846
75. Nesterova IV, Erdem SS, Pakhomov S, Hammer RP, Soper SA. Phthalocyanine dimerization-based molecular beacons using near-IR fluorescence. J Am Chem Soc. (2009) 131:2432-3. doi: 10.1021/ja8088247
76. Campo MA, Gabriel D, Kucera P, Gurny R, Lange N. Polymeric photosensitizer prodrugs for photodynamic therapy. Photochem Photobiol. (2007) 83:958-65. doi: 10.1111/j.1751-1097.2007.00090.x
77. Gabriel D, Campo MA, Gurny R, Lange N. Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes. Bioconjug Chem. (2007) 18:1070-7. doi: 10.1021/bc060321l
78. Mawn TM, Popov AV, Beardsley NJ, Stefflova K, Milkevitch M, Zheng G, et al. In Vivo detection of phospholipase c by enzyme-activated near-infrared probes. Bioconjug Chem. (2011) 22:2434-43. doi: 10.1021/bc200242v
79. Chen J, Stefflova K, Niedre MJ, Wilson BC, Chance B, Glickson JD, et al. Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. J Am Chem Soc. (2004) 126:11450-1. doi: 10.1021/ja047392k
80. Fujita N, Nagahashi A, Nagashima K, Rokudai S, Tsuruo T. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene (1998) 17:1295-304. doi: 10.1038/sj.onc.1202065
81. Gust D, Moore TA, Moore AL, Jori G, Reddi E. The photochemistry of carotenoids. Some photosynthetic and photomedical aspects. Ann NY Acad Sci. (1993) 691:32-47. doi: 10.1111/j.1749-6632.1993.tb26155.x
82. Lovell JF, Chan MW, Qi Q, Chen J, Zheng G. Porphyrin FRET acceptors for apoptosis induction and monitoring. J Am Chem Soc. (2011) 133:18580-2. doi: 10.1021/ja2083569
83. Chen J, Liu TWB, Lo P-C, Wilson BC, Zheng G. 'Zipper' molecular beacons: a generalized strategy to optimize the performance of activatable protease probes. Bioconjug Chem. (2009) 20:1836-42. doi: 10.1021/bc900207k
84. Luo D, Carter KA, Lovell JF. Nanomedical engineering: shaping future nanomedicines. Wiley Interdiscip Rev Nanomed Nanobiotechnol. (2014) 7:169-88. doi: 10.1002/wnan.1315
85. Bechet D, Couleaud P, Frochot C, Viriot M-L, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. (2008) 26:612-21. doi: 10.1016/j.tibtech.2008.07.007
86. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev. (2012) 64:102-15. doi: 10.1016/j.addr.2012.09.030
87. Gajbhiye V, Palanirajan VK, Tekade RK, Jain NK. Dendrimers as therapeutic agents: a systematic review. J Pharm Pharmacol. (2009) 61:989-1003. doi: 10.1211/jpp.61.08.0002
88. Jin R-H, Aida T, Inoue S. 'Caged' porphyrin: the first dendritic molecule having a core photochemical functionality. J Chem Soc Chem Commun. (1993) 1993:1260-2. doi: 10.1039/C39930001260
89. Cheng L, Wang C, Feng L, Yang K, Liu Z. Functional nanomaterials for phototherapies of cancer. Chem Rev. (2014) 114:10869-939. doi: 10.1021/cr400532z
90. Li W-S, Aida T. Dendrimer porphyrins and phthalocyanines. Chem Rev. (2009) 109:6047-76. doi: 10.1021/cr900186c
91. Jin CS, Zheng G. Liposomal nanostructures for photosensitizer delivery. Lasers Surg Med. (2011) 43:734-48. doi: 10.1002/lsm.21101
92. Jesorka A, Orwar O. Liposomes: technologies and analytical applications. Annu Rev Anal Chem. (2008) 1:801-32. doi: 10.1146/annurev.anchem.1.031207.112747
93. Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. (2006) 1:297
94. Derycke ASL, de Witte PAM. Liposomes for photodynamic therapy. Adv Drug Deliv Rev. (2004) 56:17-30. doi: 10.1016/j.addr.2003.07.014
95. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. (2005) 4:145-60. doi: 10.1038/nrd1632
96. Ghoroghchian PP, Frail PR, Susumu K, Blessington D, Brannan AK, Bates FS, et al. Near-infrared-emissive polymersomes: Self-assembled soft matter for in vivo optical imaging. Proc Natl Acad Sci USA. (2005) 102:2922-7. doi: 10.1073/pnas.0409394102
97. Anikeeva N, Sykulev Y, Delikatny EJ, Popov AV. Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents. Am J Nucl Med Mol Imaging. (2014) 4:507-24
98. Huynh E, Zheng G. Porphysome nanotechnology: a paradigm shift in lipid-based supramolecular structures. Nano Today (2014) 9:212-22. doi: 10.1016/j.nantod.2014.04.012
99. Hsu C-Y, Nieh M-P, Lai P-S. Facile self-assembly of porphyrin-embedded polymeric vesicles for theranostic applications. Chem Commun. (Camb.) (2012) 48:9343-5. doi: 10.1039/c2cc33851c
100. Lee JH, Shao S, Cheng KT, Lovell JF, Paik CH. 99mTc-labeled porphyrin-lipid nanovesicles. J Liposome Res. (2014). doi: 10.3109/08982104.2014.932379. [Epub ahead of print]
101. Jin CS, Lovell JF, Chen J, Zheng G. Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano (2013) 7:2541-50. doi: 10.1021/nn3058642
102. Liang X, Li X, Yue X, Dai Z. Conjugation of porphyrin to nanohybrid cerasomes for photodynamic diagnosis and therapy of cancer. Angew Chem. (2011) 123:11826-31. doi: 10.1002/ange.201103557
103. Farhadi A, Roxin A, Wilson BC, Zheng G. Nano-enabled SERS reporting photosensitizers. Theranostics (2015) 5:469-76. doi: 10.7150/thno.10694
104. Tam NCM, McVeigh PZ, MacDonald TD, Farhadi A, Wilson BC, Zheng G. Porphyrin-lipid stabilized gold nanoparticles for surface enhanced raman scattering based imaging. Bioconjug Chem. (2012) 23:1726-30. doi: 10.1021/bc300214z
105. MacDonald TD, Liu TW, Zheng G. An MRI-sensitive, non-photobleachable porphysome photothermal agent. Angew Chem. (2014) 126:7076-9. doi: 10.1002/ange.201400133
106. Liu TW, MacDonald TD, Shi J, Wilson BC, Zheng G. Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew Chem Int Ed Engl. (2012) 51:13128-31. doi: 10.1002/anie.201206939
107. Auguste DT, Furman K, Wong A, Fuller J, Armes SP, Deming TJ, et al. Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes. J Control Release. (2008) 130:266-74. doi: 10.1016/j.jconrel.2008.06.004
108. Auguste DT, Armes SP, Brzezinska KR, Deming TJ, Kohn J, Prud'homme RK. pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes. Biomaterials (2006) 27:2599-608. doi: 10.1016/j.biomaterials.2005.08.036
109. Kim MS, Lee DS. Biodegradable and pH-sensitive polymersome with tuning permeable membrane for drug delivery carrier. Chem Commun. (Camb.) (2010) 46:4481-3. doi: 10.1039/c001500h
110. Tan ML, Choong PFM, Dass CR. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides (2010) 31:184-93. doi: 10.1016/j.peptides.2009.10.002
111. Kono K, Nakashima S, Kokuryo D, Aoki I, Shimomoto H, Aoshima S, et al. Multi-functional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specific chemotherapy. Biomaterials (2011) 32:1387-95. doi: 10.1016/j.biomaterials.2010.10.050
112. Lovell JF, Jin CS, Huynh E, MacDonald TD, Cao W, Zheng G. Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles. Angew Chem. (2012) 124:2479-83. doi: 10.1002/ange.201108280
113. Jin CS, Cui L, Wang F, Chen J, Zheng G. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy. Adv Healthc Mater. (2014) 3:1240-9. doi: 10.1002/adhm.201300651
114. Carter KA, Shao S, Hoopes MI, Luo D, Ahsan B, Grigoryants VM, et al. Porphyrin-phospholipid liposomes permeabilized by near-infrared light. Nat Commun. (2014) 5:3546. doi: 10.1038/ncomms4546
115. Huynh E, Lovell JF, Fobel R, Zheng G. Optically controlled pore formation in self-sealing giant porphyrin vesicles. Small (2014) 10:1184-93. doi: 10.1002/smll.201302424
116. Rieffel J, Chen F, Kim J, Chen G, Shao W, Shao S, et al. Hexamodal imaging with porphyrin-phospholipid-coated upconversion nanoparticles. Adv Mater (2015) 27:1785-90. doi: 10.1002/adma.201404739
117. Ng KK, Lovell JF, Vedadi A, Hajian T, Zheng G. Self-assembled porphyrin nanodiscs with structure-dependent activation for phototherapy and photodiagnostic applications. ACS Nano (2013) 7:3484-90. doi: 10.1021/nn400418y
118. Trewyn BG, Giri S, Slowing II, Lin VSY. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun. (Camb.) (2007) 2007:3236-45. doi: 10.1039/B701744H
119. He Q, Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem. (2011) 21:5845-55. doi: 10.1039/C0JM03851B
120. Slowing II, Vivero-Escoto JL, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles: structural design and applications. J Mater Chem. (2010) 20:7924-37. doi: 10.1039/C0JM00554A
121. Rosenholm JM, Sahlgren C, Lindén M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-opportunities & challenges. Nanoscale (2010) 2:1870-83. doi: 10.1039/c0nr00156b
122. Lee C-H, Cheng S-H, Wang Y-J, Chen Y-C, Chen N-T, Souris J, et al. Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv Funct Mater. (2009) 19:215-22. doi: 10.1002/adfm.200800753
123. Hsiao J-K, Tsai C-P, Chung T-H, Hung Y, Yao M, Liu H-M, et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small (2008) 4:1445-52. doi: 10.1002/smll.200701316
124. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano (2008) 2:889-96. doi: 10.1021/nn800072t
125. Taylor KML, Kim JS, Rieter WJ, An H, Lin W, Lin W. Mesoporous silica nanospheres as highly efficient mri contrast agents. J Am Chem Soc. (2008) 130:2154-5. doi: 10.1021/ja710193c
126. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small (2010) 6:1952-67. doi: 10.1002/smll.200901789
127. Brevet D, Gary-Bobo M, Raehm L, Richeter S, Hocine O, Amro K, et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun. (Camb.) (2009) 2009:1475-7. doi: 10.1039/b900427k
128. Couleaud P, Morosini V, Frochot C, Richeter S, Raehm L, Durand J-O. Silica-based nanoparticles for photodynamic therapy applications. Nanoscale (2010) 2:1083-95. doi: 10.1039/C0NR00096E
129. Hocine O, Gary-Bobo M, Brevet D, Maynadier M, Fontanel S, Raehm L, et al. Silicalites and mesoporous silica nanoparticles for photodynamic therapy. Int J Pharm. (2010) 402:221-30. doi: 10.1016/j.ijpharm.2010.10.004
130. Zhao T, Wu H, Yao SQ, Xu Q-H, Xu GQ. Nanocomposites containing gold nanorods and porphyrin-doped mesoporous silica with dual capability of two-photon imaging and photosensitization. Langmuir (2010) 26:14937-42. doi: 10.1021/la102556u
131. Gary-Bobo M, Hocine O, Brevet D, Maynadier M, Raehm L, Richeter S, et al. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. Int J Pharm. (2012) 423:509-15. doi: 10.1016/j.ijpharm.2011.11.045
132. Gary-Bobo M, Mir Y, Rouxel C, Brevet D, Hocine O, Maynadier M, et al. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: drug delivery, one and two-photon photodynamic therapy. Int J Pharm. (2012) 432:99-104. doi: 10.1016/j.ijpharm.2012.04.056
133. Secret E, Maynadier M, Gallud A, Gary-Bobo M, Chaix A, Belamie E, et al. Anionic porphyrin-grafted porous silicon nanoparticles for photodynamic therapy. Chem Commun. (Camb.) (2013) 49:4202-4. doi: 10.1039/c3cc38837a
134. Zhao B, Yin J-J, Bilski PJ, Chignell CF, Roberts JE, He Y-Y. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol Appl Pharmacol. (2009) 241:163-72. doi: 10.1016/j.taap.2009.08.010
135. Qian HS, Guo HC, Ho PC-L, Mahendran R, Zhang Y. Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. Small (2009) 5:2285-90. doi: 10.1002/smll.200900692
136. Tu J, Wang T, Shi W, Wu G, Tian X, Wang Y, et al. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape. Biomaterials (2012) 33:7903-14. doi: 10.1016/j.biomaterials.2012.07.025
137. Wang T, Zhang L, Su Z, Wang C, Liao Y, Fu Q. Multifunctional hollow mesoporous silica nanocages for cancer cell detection and the combined chemotherapy and photodynamic therapy. ACS Appl Mater Interfaces. (2011) 3:2479-86. doi: 10.1021/am200364e
138. Nguyen KT, West JL. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials (2002) 23:4307-14. doi: 10.1016/S0142-9612(02)00175-8
139. Van Vlierberghe S, Dubruel P, Schacht E. Biopolymer-based hydrogels as scaffolds for tissue engineering applications: a review. Biomacromolecules (2011) 12:1387-408. doi: 10.1021/bm200083n
140. Balakrishnan B, Banerjee R. Biopolymer-based hydrogels for cartilage tissue engineering. Chem Rev. (2011) 111:4453-74. doi: 10.1021/cr100123h
141. Park H, Park K, Shalaby WSW. Biodegradable Hydrogels for Drug Delivery. Technomic Publishing Company, Inc. (1993). 272 p
142. Brandl F, Kastner F, Gschwind RM, Blunk T, Teßmar J, Göpferich A. Hydrogel-based drug delivery systems: comparison of drug diffusivity and release kinetics. J Control Release. (2010) 142:221-8. doi: 10.1016/j.jconrel.2009.10.030
143. Hah HJ, Kim G, Lee Y-EK, Orringer DA, Sagher O, Philbert MA, et al. Methylene blue-conjugated hydrogel nanoparticles and tumor-cell targeted photodynamic therapy. Macromol Biosci. (2011) 11:90-9. doi: 10.1002/mabi.201000231
144. Donnelly RF, Cassidy CM, Loughlin RG, Brown A, Tunney MM, Jenkins MG, et al. Delivery of methylene blue and meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate from cross-linked poly(vinyl alcohol) hydrogels: a potential means of photodynamic therapy of infected wounds. J Photochem Photobiol B. (2009) 96:223-31. doi: 10.1016/j.jphotobiol.2009.06.010
145. Fallows SJ, Garland MJ, Cassidy CM, Tunney MM, Singh TRR, Donnelly RF. Electrically-responsive anti-adherent hydrogels for photodynamic antimicrobial chemotherapy. J Photochem Photobiol B. (2012) 114:61-72. doi: 10.1016/j.jphotobiol.2012.05.011
146. Bonnett R, Buckley DG, Burrow T, Galia ABB, Saville B, Songca SP. Photobactericidal materials based on porphyrins and phthalocyanines. J Mater Chem. (1993) 3:323-4. doi: 10.1039/JM9930300323
147. Parsons C, McCoy CP, Gorman SP, Jones DS, Bell SEJ, Brady C, et al. Anti-infective photodynamic biomaterials for the prevention of intraocular lens-associated infectious endophthalmitis. Biomaterials (2009) 30:597-602. doi: 10.1016/j.biomaterials.2008.10.015
148. Lv F, Mao L, Liu T. Thermosensitive porphyrin-incorporated hydrogel with four-arm PEG-PCL copolymer: preparation, characterization and fluorescence imaging in vivo. Mater Sci Eng C. (2014) 43:221-30. doi: 10.1016/j.msec.2014.07.019
149. Jang B, Park J-Y, Tung C-H, Kim I-H, Choi Y. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano (2011) 5:1086-94. doi: 10.1021/nn102722z
150. Camerin M, Rello-Varona S, Villanueva A, Rodgers MAJ, Jori G. Metallo-naphthalocyanines as photothermal sensitisers for experimental tumours: in vitro and in vivo studies. Lasers Surg Med. (2009) 41:665-73. doi: 10.1002/lsm.20846
151. Lim C-K, Shin J, Lee Y-D, Kim J, Oh KS, Yuk SH, et al. Phthalocyanine-aggregated polymeric nanoparticles as tumor-homing near-infrared absorbers for photothermal therapy of cancer. Theranostics (2012) 2:871. doi: 10.7150/thno.4133
152. Pawlicki M, Collins HA, Denning RG, Anderson HL. Two-photon absorption and the design of two-photon dyes. Angew Chem Int Ed Engl. (2009) 48:3244-66. doi: 10.1002/anie.200805257
153. Kuimova MK, Collins HA, Balaz M, Dahlstedt E, Levitt JA, Sergent N, et al. Photophysical properties and intracellular imaging of water-soluble porphyrin dimers for two-photon excited photodynamic therapy. Org Biomol Chem. (2009) 7:889-96. doi: 10.1039/B814791D
154. Balaz M, Collins HA, Dahlstedt E, Anderson HL. Synthesis of hydrophilic conjugated porphyrin dimers for one-photon and two-photon photodynamic therapy at NIR wavelengths. Org Biomol Chem. (2009) 7:874-88. doi: 10.1039/B814789B
155. Odom SA, Webster S, Padilha LA, Peceli D, Hu H, Nootz G, et al. Synthesis and two-photon spectrum of a bis(Porphyrin)-substituted squaraine. J Am Chem Soc. (2009) 131:7510-1. doi: 10.1021/ja901244e
156. Wu C, Xu Q-H. Enhanced one-and two-photon excitation emission of a porphyrin photosensitizer by FRET from a conjugated polyelectrolyte. Macromol Rapid Commun. (2009) 30:504-8. doi: 10.1002/marc.200800655
157. Poon C-T, Chan P-S, Man C, Jiang F-L, Wong RNS, Mak N-K, et al. An amphiphilic ruthenium(II)-polypyridyl appended porphyrin as potential bifunctional two-photon tumor-imaging and photodynamic therapeutic agent. J Inorg Biochem. (2010) 104:62-70. doi: 10.1016/j.jinorgbio.2009.10.004
158. Secret E, Maynadier M, Gallud A, Chaix A, Bouffard E, Gary-Bobo M, et al. Two-photon excitation of porphyrin-functionalized porous silicon nanoparticles for photodynamic therapy. Adv Mater. (2014) 26:7643-8. doi: 10.1002/adma.201403415
159. Bullous AJ, Alonso CMA, Boyle RW. Photosensitiser-antibody conjugates for photodynamic therapy. Photochem Photobiol Sci. (2011) 10:721-50. doi: 10.1039/C0PP00266F
160. Mir Y, Elrington SA, Hasan T. A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer. Nanomedicine (2013) 9:1114-22. doi: 10.1016/j.nano.2013.02.005
161. Patel H, Mick R, Finlay J, Zhu TC, Rickter E, Cengel KA, et al. Motexafin lutetium-photodynamic therapy of prostate cancer: short and long term effects on PSA. Clin Cancer Res. (2008) 14:4869. doi: 10.1158/1078-0432.CCR-08-0317
162. Alonso CM, Palumbo A, Bullous AJ, Pretto F, Neri D, Boyle RW. Site-specific and stoichiometric conjugation of cationic porphyrins to antiangiogenic monoclonal antibodies. Bioconjug Chem. (2010) 21:302-13. doi: 10.1021/bc9003537
163. Mew D, Wat C-K, Towers G, Levy J. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol. (1983) 130:1473-7
164. Goff BA, Bamberg M, Hasan T. Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res. (1991) 51:4762-7
165. Hudson R, Carcenac M, Smith K, Madden L, Clarke OJ, Pelegrin A, et al. The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br J Cancer. (2005) 92:1442-9. doi: 10.1038/sj.bjc.6602517
166. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med. (2011) 17:1685-91. doi: 10.1038/nm.2554
167. Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug Chem. (2012) 23:604-9. doi: 10.1021/bc200648m
168. Sano K, Nakajima T, Choyke PL, Kobayashi H. Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano (2012) 7:717-24. doi: 10.1021/nn305011p
169. Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I, et al. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor. Mol Oncol. (2014) 8:620-32. doi: 10.1016/j.molonc.2014.01.006
170. Sato K, Hanaoka H, Watanabe R, Nakajima T, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer. Mol Cancer Ther. (2015) 14:141-50. doi: 10.1158/1535-7163.MCT-14-0658
171. Chen B, Pogue BW, Hoopes PJ, Hasan T. Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr. (2006) 16:279-306. doi: 10.1615/CritRevEukarGeneExpr.v16.i4.10
172. Molema G. Tumor vasculature directed drug targeting: applying new technologies and knowledge to the development of clinically relevant therapies. Pharm Res. (2002) 19:1251-8. doi: 10.1023/A:1020312220968
173. Brandis A, Mazor O, Neumark E, Rosenbach-Belkin V, Salomon Y, Scherz A. Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins. Photochem Photobiol. (2005) 81:983-92. doi: 10.1111/j.1751-1097.2005.tb01473.x
174. Reddy GR, Bhojani MS, McConville P, Moody J, Moffat BA, Hall DE, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res. (2006) 12:6677-86. doi: 10.1158/1078-0432